FTC: Minor Drug Changes To Prolong Monopoly May Violate Antitrust Law
On November 21, 2012, the U.S. Federal Trade Commission filed in the U.S. District Court for the Eastern District of Pennsylvania an amicus brief contending that minor, non-therapeutic changes to branded pharmaceutical products may violate U.S. antitrust law if the changes … Continue reading